1. Home
  2. NMG vs CTKB Comparison

NMG vs CTKB Comparison

Compare NMG & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nouveau Monde Graphite Inc.

NMG

Nouveau Monde Graphite Inc.

HOLD

Current Price

$2.94

Market Cap

448.1M

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.67

Market Cap

433.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMG
CTKB
Founded
2011
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.1M
433.8M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
NMG
CTKB
Price
$2.94
$4.67
Analyst Decision
Strong Buy
Hold
Analyst Count
3
4
Target Price
$4.22
$5.88
AVG Volume (30 Days)
480.2K
1.9M
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$196,828,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$2.37
52 Week High
$6.06
$7.30

Technical Indicators

Market Signals
Indicator
NMG
CTKB
Relative Strength Index (RSI) 52.11 41.56
Support Level $2.80 $4.79
Resistance Level $3.18 $5.16
Average True Range (ATR) 0.19 0.24
MACD 0.00 -0.12
Stochastic Oscillator 59.27 3.41

Price Performance

Historical Comparison
NMG
CTKB

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: